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Abstract
Background: A recent weakening and even decoupling of the association of body mass index (BMI) and systolic
blood pressure (SBP) in population data was reported, i. a. for Western Europe.
Methods: The association of BMI and SBP in recent cross-sectional population data from Germany was investigated
in participants aged 18–79 years with BMI 17.5-40 kg/m2 from national health examination surveys 1998 (n = 6,931)
and 2008–2011 (n = 6,861) in Germany. The association was analyzed both in the overall samples and in participants
without antihypertensive medication.
Results: From 1998 to 2008–11, age- and sex-standardized mean SBP decreased from 129.0 (CI 128.2-129.7) to 124.1
(123.5-124.6) mmHg in all participants and from 126.0 (125.4-126.7) to 122.3 (121.7-122.8) mmHg among persons not
on antihypertensive medication. The proportion of persons treated with antihypertensives augmented from 19.2 %
(17.7-20.8) to 25.3 % (24.0-26.6). Mean BMI remained constant at around 27 kg/m2 with a slight increase in obesity
prevalence. BMI was positively associated with SBP both in 1998 and 2008–11, yet the association tended to level out
with increasing BMI suggesting a non-linear association. The strength of the BMI-SBP-association decreased over time
in all and untreated men. In women, the association weakened in the overall sample, but remained similarly strong in
untreated women. The unadjusted linear regression models were used to estimate the increase in SBP within 5-unit
BMI increases. E. g. for men in 1998, SBP was higher by 7.0 mmHg for a BMI increase from 20 to 25 kg/m2 and by
3.6 mmHg for BMI 30 to 35 kg/m2. The corresponding values for 2008–11 were 3.8 mmHg and 1.7 mmHg.
Conclusions: The cross-sectional association of BMI and SBP decreased between 1998 and 2008–11 in Germany,
however it did not disappear and it is in part explained by improvements in the diagnosis and treatment of high blood
pressure.
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Background
High blood pressure (BP) represents the leading single
risk factor for overall mortality and burden of disease
globally [1, 2]. In 2001, 17.6 % of all premature deaths as
well as 9.3 % of disability-adjusted-life-years (DALYs)
were attributable to raised BP [3] and more than one
third of the population in high-income countries had
hypertension [2].
A positive association of overweight and BP has been
reported from numerous cross-sectional and prospective
studies over many decades [4, 5]. The INTERSALT
study, which included cross-sectional data from 32
countries, estimated that after multivariable adjustment
a one-unit increase in body mass index (BMI) was asso-
ciated with a 0.91 mmHg systolic blood pressure (SBP)
increase in men and 0.72 mmHg in women [6].
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During the last decades, opposite population trends in
the development of BP and BMI have been observed in
many countries. While the prevalence of overweight and
obesity was still rising or remained constant on a high level,
i.e. in the U.S. [7] and most Western European countries
[8] including Germany [9], BP declined in these populations
during the same period [10–12]. This suggests that the
strength of the BMI-SBP-association may have decreased
over time. Most recently, even a dissociation of BP from
BMI at the population level was reported: the Global Bur-
den of Metabolic Risk Factors of Chronic Diseases Collab-
orating Group, with country-level risk estimates from 199
countries, showed a positive cross-sectional association of
SBP and BMI for western European men and women in
1980, but no association with 2008 data [13]. This study
could not account for antihypertensive medication use
which increased worldwide in these decades, thus truncat-
ing the BP distribution and diminishing the SBP-BMI-
correlation, particularly in the obese.
However, a significantly decreasing BMI-SBP-associ-
ation was also reported for persons not on antihyper-
tensive treatment from two cross-sectional surveys
conducted in 1989 and 2004 at the Seychelles [14].
Similarly, data from seven population-based studies
with 9- to 11-year old U.K. children found a weakening
in the association, too [15]. Additional indirect evidence
was given by an analysis of data from the National
Health and Nutrition Examination Survey (NHANES)
conducted among adults and children of the United
States, where the prevalence of high BP decreased more
in overweight and obese persons than in lean persons
over time, although a survey x BMI group interaction
was not significant indicating that the declines in high
BP did not differ by BMI [16].
The aim of the present study was to investigate changes
in the cross-sectional BMI-SBP-association in the general
population in Germany between 1998 and 2008–2011 tak-
ing into account the impact of an increased use of antihy-
pertensive medication. Therefore, data from two
population-based national health surveys, the German
National Health Interview and Examination Survey 1998
(GNHIES98) and the German Health Interview and
Examination Survey for Adults 2008–11 (DEGS1) were
analysed, both the overall samples and the subsamples of
participants not taking antihypertensive medication.
Methods
Study population
Two national health examination surveys were con-
ducted in Germany in 1998 and 2008–2011. Both used a
nationwide two-stage clustered sample design with se-
lection of study points based on community type and
federal state and subsequent sampling of persons aged
18–79 years stratified by sex and age group from the
local population registers [17, 18]. The German Health
Interview and Examination Survey for Adults (DEGS1)
2008–2011 comprised a total of n = 7,115 persons exam-
ined at one of 180 study points, of whom n = 4,192 were
first-time participants (response: 42 %) and n = 2,923 (re-
sponse: 62 %) were former participants of the German
National Health Interview and Examination Survey 1998
(GNHIES98). The net sample of the GNHIES98 con-
sisted of n = 7,124 persons (response: 61 %) from 120
study points. The study was approved by the ethical
committee of Charité University Medicine, Berlin, and
by the Federal Commissioner for Data Protection and
Freedom of Information. Informed written consent and
assent were obtained from all participants.
Measurement and survey methods
BP was measured according to a standardized protocol
which was almost identical in both surveys, except that
the standard mercury sphygmomanometer (Erkameter
3000, Bad Tölz, Germany) employed in the GNHIES98
was replaced by an automated oscillometric Datascope
Accutorr Plus device (Datascope Accutorr Plus, Mahwah,
NJ, USA) together with a new set of manufacturer-
provided cuffs and adapted cuff-selection-rules. The par-
ticipants sat quiet and upright on a height-adjustable chair
with their back supported, the right forearm was resting
on a table at heart level, elbow slightly bent, legs
uncrossed and feet firmly on the floor. The correct cuff
size was determined with the upper arm circumference
(AC) measured half way between the acromion and the
olecranon. Both surveys used three cuff sizes. The cuff
bladder dimensions (width × length) in DEGS1 were:
10.5 × 23.9 cm for ACs of 21–27.9 cm, 13.5 × 30.7 cm
for ACs of 28–35.9 cm and 17 × 38.6 cm for ACs of
36–46 cm. The corresponding sizes in GNHIES98 were:
8 × 20 cm for ACs < 20 cm, 12 × 28 cm for ACs of 20–
40 cm and 14 × 40 cm for ACs > 40 cm. The correct
position of the cuff above the brachial artery was en-
sured with a mark on the cuff. Three blood pressure
measurements were taken at 3-min intervals, following
an initial 5-min resting period (GNHIES98: 3 min) after
a non-strenuous part of the examination.
The participants were asked to bring along their medi-
cation of the previous 7 days and antihypertensive medica-
tion use was defined according to the WHO Anatomic
Therapeutic Chemical Classification System (ATC): anti-
hypertensive drugs (C02), diuretics (C03), beta-blockers
(C07), calcium channel blockers (C08) and ACE inhibitors
(C09). Hypertension was defined as: SBP ≥140 mmHg or
DBP ≥90 mmHg or treatment with ATC-coded antihyper-
tensive medication. However, the antihypertensive medi-
cation was only used for defining hypertension if the
participants reported having hypertension since the
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indication for taking these drugs may be other than
hypertension.
Body height and weight measurements also followed
standardized procedures with the participants dressed
only in underwear without shoes. Body height was mea-
sured with a portable stadiometer (Holtain Ltd., UK,
precision: 0.1 cm) and body weight with a calibrated
electronic scale (SECA, column scale 930, precision:
0.1 kg). BMI was calculated as weight in kilogram (kg)
divided by height in meter squared (m2) and BMI was
used to define non-overweight (BMI < 25 kg/m2), over-
weight (BMI ≥ 25 to <30 kg/m2) and obesity (BMI ≥
30 kg/m2).
Information on lifestyle and socio-demographic vari-
ables were obtained with a self-administered question-
naire. Social status was determined using an index with
information on school education and vocational training,
occupational status and net household income (weighted
by household needs) permitting classification into low,
middle and high status groups [19]. Alcohol consump-
tion was calculated in gram/day (g/d) on basis of ques-
tions about consumption frequency and amount of beer,
light beer, alcohol-free beer, wine and liquor. Alcohol in
g/day was then divided into three classes according to
German guidelines on tolerable upper intake levels: non-
drinker (0 g/d), light drinker (men: >0 to 20 g/d,
women: >0 to 10 g/d) and heavy drinker (men: >20 g/d,
women: >10 g/d) [20]. Smoking status was assessed by
smoking frequency (daily, occasionally, no longer,
never) and amount of cigarettes smoked per day and
was categorized into current daily smoker (≥1 cigarette
per day) or non-smoker (including occasional smoker
and ex-smoker). Sports activity was asked with “How
often do you exercise?” and the response items were:
“no sports activity”, “<1 h/week”, “1-2 h/ week”, “2-4 h/
week” and “>4 h/week”. This information was sub-
sumed into three groups: no sports activity, sports ac-
tivity <2 h/week and sports activity >2 h/week.
Analysis
Analyses were performed in 18–79 year old GNHIES98
and DEGS1 participants. Exclusion criteria were missing
information on BP (GNHIES98: 0.2 %, DEGS1: 0.3 %),
antihypertensive medication use (GNHIES98: 0.4 %,
DEGS1: 0.3 %) or BMI (GNHIES98: 0.7 %, DEGS1:
0.7 %). In addition, BMI outliers <17.5 kg/m2 or >40 kg/
m2 (GNHIES98: n = 193, 2.7 %; DEGS1: n = 215, 3 %)
were excluded since the aim of the study was to describe
the BP-BMI association over a BMI range that is com-
mon in the general population, while at the lowest and
highest extremes of BMI a ceiling effect on BP is likely.
Analyses were first run for all participants (n = 6,931 for
GNHIES98 and n = 6,861 for DEGS1), then for
participants without antihypertensive medication as de-
fined above (n = 5,663 for GNHIES98 and 4,755 for
DEGS1).
The average of the second and third blood pressure
measurements were used for analysis. The GNHIES98
BP data were calibrated for comparison with DEGS1
data based on a formula from a methodological study
described previously [21]. In brief, the GNHIES98 and
DEGS1 BP protocols were compared according to the
principles of the International Protocol revision 2010 for
the validation of blood pressure measuring devices in
adults of the European Society of Hypertension in a
measurement sequence with 105 participants yielding
315 measurement pairs. SBP and DBP values were
higher with the mercury sphyghmomanometer in the
GNHIES98 protocol as compared to the Datascope mea-
surements with the DEGS1 protocol. Measurement dif-
ferences increased with BP, pulse pressure, the difference
in the ratio of cuff width to arm circumference, age and
sex (higher mean difference in men compared to
women).
The DEGS1 data were weighted to the population in
Germany as of 31 Dec 2010 with respect to age, sex, re-
gion and nationality as well as type of municipality and
education. The weighting factor for DEGS1 considered
the re-participation probability of the former GNHIES98
participants based on a logistic regression model [17].
The GNHIES98 data were also weighted to the popula-
tion structure as of 31 Dec 2010, but to the 1998 educa-
tional distribution because of the secular changes in
education levels. All analyses were weighted, so that the
differences observed are controlled for age and sex.
Mean SBP, DBP and the prevalence of hypertensive BP
(≥140/90 mmHg) and hypertension (BP ≥140/90 mmHg
or taking ATC-coded antihypertensive medication in
case of known hypertension) were assessed in both sexes
and in subgroups of age, BMI, antihypertensive medical
treatment, alcohol consumption, physical activity, smok-
ing status and socioeconomic status (SES) for both sur-
veys. Differences between the surveys were tested with
chi-squared tests for categorical variables and t-tests for
continuous variables. Tests were considered significant if
p ≤ 0.05. To visualize the association of BMI with SBP,
scatterplots of BMI and SBP were produced by combin-
ing the following two plots in one graph: 1.) BMI was di-
vided into 5 % BMI percentile ranges (<P5, P5-P10 etc.
up to P95-P100) and the mean BMI and mean SBP were
plotted for these percentile ranges; 2.) curves of pre-
dicted SBP values from unadjusted linear regression
models of SBP on BMI, including BMI squared (BMI2).
Generalized linear regression analyses were conducted
separately for GNHIES98 and DEGS1 and were stratified
by sex (since a BMI x sex interaction was significant,
p = 0.000) and treatment (all and untreated participants).
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BMI2 was included to allow for a non-linear association
of BMI and SBP. The significance of the BMI-SBP-
association was tested in a combined test for BMI and
BMI2.
To investigate whether the BMI-SBP-association chan-
ged between 1998 and 2008–11, both surveys were
combined and a BMI × survey and BMI2 × survey inter-
action were included in the model. The significance of
the interaction was tested in a combined test for BMI ×
survey and BMI2 × survey. Moreover, all analyses were
adjusted for selected covariates including age, antihyper-
tensive medication, alcohol consumption, physical
Table 1 Selected characteristics of participants aged 18–79 years in 1998 and 2008-11
All participants Untreated participants
1998 2008-2011 1998 2008-2011
N 6,931 6,861 5,663 4,755
% 95 %-CI % 95 %-CI p % 95 %-CI % 95 %-CI p
Men 50.3 ( 49.1 - 51.6 ) 50.3 ( 48.7 - 51.9 ) 51.7 ( 50.3 - 53.1 ) 50.6 ( 48.7 - 52.5 )
Women 49.7 ( 48.4 - 50.9 ) 49.7 ( 48.1 - 51.3 ) 48.3 ( 46.9 - 49.7 ) 49.4 ( 47.5 - 51.3 )
Mean age (years) 47.4 ( 46.7 - 48.1 ) 47.4 ( 46.9 - 47.8 ) 43.6 ( 43.0 - 44.3 ) 42.1 ( 41.6 - 42.5 )
Age groups
18-29 years 17.4 ( 16.1 - 18.7 ) 18.9 ( 18.0 - 19.8 ) 21.3 ( 19.8 - 22.9 ) 25.1 ( 24.0 - 26.3 )
30-44 years 26.8 ( 25.5 - 28.1 ) 25.2 ( 24.0 - 26.4 ) 31.7 ( 30.4 - 33.1 ) 31.7 ( 30.3 - 33.1 )
45-64 years 36.6 ( 35.3 - 37.9 ) 36.4 ( 35.0 - 37.8 ) 35.6 ( 34.2 - 37.1 ) 34.7 ( 32.9 - 36.5 )
65-79 years 19.3 ( 17.7 - 21.0 ) 19.5 ( 18.5 - 20.6 ) 11.3 ( 10.0 - 12.7 ) 8.5 ( 7.7 - 9.3 )
BMI class
17,5-25 kg/m2 38.7 ( 37.0 - 40.5 ) 40.6 ( 39.0 - 42.2 ) 0.070 44.1 ( 42.1 - 46.1 ) 48.6 ( 46.6 - 50.6 ) 0.000
≥25-30 kg/m2 41.0 ( 39.6 - 42.3 ) 37.3 ( 36.0 - 38.7 ) 0.000 39.8 ( 38.2 - 41.3 ) 36.2 ( 34.6 - 37.8 ) 0.001
≥30-40 kg/m2 20.3 ( 18.9 - 21.8 ) 22.1 ( 20.7 - 23.6 ) 0.045 16.1 ( 14.7 - 17.7 ) 15.2 ( 13.8 - 16.7 ) 0.353
Mean SBP
(mmHg)
129.0 ( 128.2 - 129.7 ) 124.1 ( 123.5 - 124.6 ) 0.000 126.0 ( 125.4 - 126.7 ) 122.3 ( 121.7 - 122.8 ) 0.000
Mean DBP
(mmHg)
78.2 ( 77.8 - 78.7 ) 73.3 ( 72.9 - 73.6 ) 0.000 77.0 ( 76.5 - 77.4 ) 72.9 ( 72.5 - 73.2 ) 0.000
Hypertension
prevalencea
29.4 ( 27.6 - 31.2 ) 31.2 ( 29.6 - 32.8 ) 0.113 / ( / - / ) / ( / - / ) /
Prevalence BP
≥140/90 mmHg
22.8 ( 21.1 - 24.6 ) 15.3 ( 14.0 - 16.8 ) 0.000 15.9 ( 14.5 - 17.4 ) 11.4 ( 10.1 - 12.8 ) 0.000
Antihypertensive
medication
19.2 ( 17.7 - 20.8 ) 25.3 ( 24.0 - 26.6 ) 0.000 / ( / - / ) / ( / - / ) /
Daily smoker 26.5 ( 24.9 - 28.1 ) 23.7 ( 22.2 - 25.2 ) 0.001 29.9 ( 28.1 - 31.7 ) 26.9 ( 25.1 - 28.8 ) 0.005
Alcoholb
0 g/d 19.6 ( 18.2 - 21.1 ) 14.4 ( 13.3 - 15.6 ) 0.000 17.8 ( 16.3 - 19.4 ) 14.0 ( 12.7 - 15.5 ) 0.000
<10/20 g/d 61.2 ( 59.6 - 62.9 ) 69.5 ( 68.0 - 70.9 ) 0.000 62.7 ( 60.8 - 64.6 ) 70.5 ( 68.8 - 72.2 ) 0.000
>10/20 g/d 19.2 ( 17.7 - 20.7 ) 16.1 ( 15.0 - 17.2 ) 0.000 19.5 ( 17.9 - 21.2 ) 15.5 ( 14.1 - 16.9 ) 0.000
Sports activity
>2 h/week 19.1 ( 17.7 - 20.6 ) 25.8 ( 24.3 - 27.3 ) 0.000 21.0 ( 19.5 - 22.6 ) 27.6 ( 25.9 - 29.4 ) 0.000
<2 h/week 32.0 ( 30.6 - 33.5 ) 41.6 ( 40.0 - 43.1 ) 0.000 33.9 ( 32.3 - 35.5 ) 42.0 ( 40.2 - 43.9 ) 0.000
no sports activity 48.9 ( 46.9 - 50.9 ) 32.7 ( 31.1 - 34.3 ) 0.000 45.1 ( 43.2 - 47.1 ) 30.4 ( 28.6 - 32.2 ) 0.000
Socioeconomic
status (SES)
low 19.4 ( 17.6 - 21.3 ) 19.6 ( 18.0 - 21.2 ) 0.834 18.3 ( 16.5 - 20.3 ) 18.7 ( 17.1 - 20.4 ) 0.726
medium 60.5 ( 59.0 - 62.1 ) 60.4 ( 58.7 - 62.1 ) 0.905 60.9 ( 59.1 - 62.6 ) 59.7 ( 57.7 - 61.7 ) 0.320
high 20.1 ( 18.2 - 22.2 ) 20.0 ( 18.4 - 21.8 ) 0.929 20.8 ( 18.9 - 22.9 ) 21.6 ( 19.7 - 23.6 ) 0.445
Hypertension prevalence was defined as BP ≥140/90 mmHg or antihypertensive medication use in case of physician-diagnosed known hypertension
Alcohol intake in gram/day (g/d) was categorized on basis of the upper tolerable intake level (UL). The alcohol UL is set on 10 g/d for women and 20 g/d for men
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activity, smoking status and SES. The analyses were
computed with the complex samples option in SPSS
20.0, using the LMATRIX option for the combined tests.
Results
Selected characteristics of all and untreated study partic-
ipants 1998 and 2008–2011 are shown in Table 1. Be-
tween 1998 and 2008–11, mean SBP decreased by
5 mmHg (from 129.0 mmHg to 124.1 mmHg, p = 0.000)
in all participants, and in untreated participants by
4 mmHg (from 126.0 mmHg to 122.3 mmHg, p = 0.000)
(Table 1). In women, mean SBP was lower in 2008–11
by −6.6 mmHg for all women and −5.4 mmHg for un-
treated women compared to 1998, in men −3.3 mmHg
among all men and −2.0 mmHg among untreated men.
SBP was positively associated with age at both time
points, although the increase in SBP with age was
steeper in 1998 than in 2008–11. Moreover, the preva-
lence of hypertensive BP (≥140/90 mmHg) decreased
from 22.8 % in 1998 to 15.3 % in 2008–11 among all
and from 15.9 % to 11.4 % among untreated participants
(Table 1).
During the same period, mean BMI remained constant
at a high level (around 27 kg/m2 in men and 26 kg/m2
in women). The prevalence of obesity slightly increased
in men from 19.0 % to 22.4 % (p = 0.006) and remained
at around 22 % (p = 0.912) in women. In both surveys,
the obesity prevalence increased continuously with age
in women, but it reached a plateau at the age of 60–69
years in men (data not shown). Obesity prevalence in
the untreated group did not change over time (16.1 % in
1998 and 15.2 % in 2008–11, p = 0.353) and was lower at
both times than in the overall group (Table 1).
The decrease in mean SBP over time was more pro-
nounced in overweight (−4.9 mmHg) and obese persons
(−6.9 mmHg) than in non-overweight participants
(−3.7 mmHg). Untreated overweight (−3.5 mmHg) and
obese (−4.3 mmHg) participants also showed a greater
decrease in mean SBP than non-overweight ones
(−3.1 mmHg). The prevalence of hypertensive BP (≥140/
90 mmHg) decreased by more than one third among all
BMI groups (Table 2). Nevertheless, overweight and
obese individuals still had a notably higher mean SBP
and higher prevalence of hypertensive BP in 2008–11
than non-overweight individuals (Table 2).
The proportion of persons taking antihypertensive
medication (irrespective of indication) augmented
significantly from 19.2 % in 1998 to 25.3 % in 2008–
11 (p = 0.000; Table 1). Thereby, the treatment pro-
portion was higher in overweight and obese persons
than in non-overweight individuals (Table 2),
whereby 35.8 % of obese persons were treated in
1998 and almost half of all obese (48.5 %) received
antihypertensives in 2008–11 (p = 0.000). However,
the relative increase in treatment over time
amounted to approximately 30 %, irrespective of
BMI group.
Figure 1 illustrates the association of BMI with SBP
separately for all and untreated men and women in 1998
and 2008–11. Mean SBP was plotted against BMI for
subgroups defined by narrow BMI percentile ranges.
Following from these plots, BMI was positively associ-
ated with SBP in all and untreated participants at both
times, yet the association tended to level out with in-
creasing BMI suggesting a non-linear association of BMI
and SBP. Table 3 shows the unadjusted linear regression
models of SBP and BMI, which included BMI2. BMI2
thereby was significant at the p < 0.05 level for all men
and all women in 1998 as well as all and untreated
women in 2008–11 (not significant for all and untreated
men in 2008–11 as well as untreated men and women in
1998, data not shown). The regression curves from these
models are also shown in Fig. 1. The level of SBP for a
given BMI was generally lower in 2008–11 than in 1998.
The association between BMI and SBP was also com-
pared across age groups (18–39 years, 40–59 years, 60–
79 years) in an age-stratified analysis (Additional file 1)
as well as by adding an interaction term of BMI ×
agegroup and BMI2 × agegroup to all models described
above. These interactions were not statistically signifi-
cant (combined p > 0.05) in any model but one, i.e. “all
men” in 2008–11. The association of BMI and SBP by
age group in untreated men and women is graphically
depicted in an additional figure (Additional file 2).
The strength of the BMI-SBP-association decreased
over time in men (both all and untreated) as shown in a
regression analysis with combined data from the two
surveys which included an interaction term of BMI ×
survey (Table 3). This weakening was also observed after
adjustment for age, antihypertensive medication, alcohol
intake, sports activity, smoking status and SES. In
women, the association became weaker only in the overall
analysis including treated participants (both unadjusted
and adjusted). No change of the BMI-SBP- association
was observed in untreated women (unadjusted and
adjusted) (Tables 3 and 4).
In a further analysis, the association of BMI and
SBP was assessed only in untreated participants with
hypertension. In this group, however, BMI was no
longer associated with SBP neither in 1998 nor in
2008–11 (Additional file 3).
Finally, Table 4 exemplifies the SBP increase with
rising BMI separately for men and women, estimated
from the unadjusted regression models. Accordingly,
in 1998 a BMI increase from 20 kg/m2 to 25 kg/m2
was associated with an estimated SBP higher by
7.0 mmHg in men and 8.4 mmHg in women,
whereas a BMI increase from 30 kg/m2 to 35 kg/m2
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was linked to a 3.6 mmHg and 3.9 mmHg higher SBP in
men and women, respectively. In 2008–11, SBP increased
less with BMI, especially in men, where SBP was higher by
3.8 mmHg for a BMI augmenting from 20 kg/m2 to
25 kg/m2 and 1.7 mmHg for 30 kg/m2 to 35 kg/m2. The
corresponding estimates for women were 7.6 mmHg and
2.0 mmHg. A similar pattern was seen in untreated partic-
ipants, although the estimated increase in SBP was less
than among all participants (e.g. men in 1998, BMI
increase 20 to 25 kg/m2: 6.2 mmHg, 2008–11: 3.7 mmHg;
Table 4)
Discussion
This study shows that in Germany both in 1998 and in
2008–11 SBP is still associated with BMI both in the
overall general adult population and in the population
not taking antihypertensive medication. Thus, we cannot
confirm previous findings about a disappearance of the
BMI-SBP-association at the population level in world-
wide data [13]. We did however find a weakening of the
association over time in the overall samples of men and
women as well as in untreated men, while in untreated
women the association did not change significantly.
The Global Burden of Metabolic Risk Factors of
Chronic Diseases Project analyses had shown a decoup-
ling of the BMI-SBP-association between 1980 and 2008
on a global scale as well as for high-income regions like
Western Europe and North America based on country-
level aggregated data from 199 nations. A one unit higher
mean population BMI was associated with a 1.35 mmHg
(CI 1.05 - 1.80) higher mean SBP in women and
1.19 mmHg (CI 1.01 - 1.54) in men in 1980, but this posi-
tive association seemed to have disappeared in 2008 [13].
However, the analyses did not account for other influential
factors like antihypertensive medication use and were con-
strained to a linear analysis of population means.
The findings of our study are in line with analyses
of two cross-sectional surveys from the Seychelles
comparing the BMI-SBP association in 1989 and
2004. In these studies a significant decline in the
strength of the adjusted association of BMI and BP
was observed and was not explained by the increased
proportion of persons treated with antihypertensives.
Among untreated participants, a one-unit BMI in-
crease was thereby associated with a 1.98 mmHg
higher SBP in 1989 but only 1.27 mmHg in 2004
after multivariable adjustment. Furthermore, a signifi-
cant weakening but not decoupling of the BMI-SBP-
association was also found for 9- to 11-year-old U.K.
children when comparing 1980 and 2008 data [15]. In
contrast, other recent studies did not support a de-
creasing association of BMI and SBP in adults in
France [22], Taiwan [23], Switzerland [24] as well as
in both children and adults in the Seychelles [24, 25].
Table 2 Blood pressure by BMI class in all and untreated participants in 1998 and 2008-11




mmHg 95 %-CI mmHg 95 %-CI % %
All participants
17.5-25 kg/m2 123.4 ( 122.4 - 124.3 ) 75.2 ( 74.6 - 75.7 ) 12.3 8.0
≥25-30 kg/m2 131.1 ( 130.2 - 132.0 ) 79.2 ( 78.6 - 79.7 ) 26.2 21.6
≥30-40 kg/m2 135.4 ( 134.2 - 136.7 ) 82.2 ( 81.6 - 82.9 ) 35.9 35.8
Untreated participants
17.5-25 kg/m2 121.8 ( 121.0 - 122.6 ) 74.5 ( 73.9 - 75.0 ) 8.6 /
≥25-30 kg/m2 128.3 ( 127.5 - 129.2 ) 78.1 ( 77.6 - 78.7 ) 19.2 /
≥30-40 kg/m2 131.9 ( 130.7 - 133.1 ) 80.9 ( 80.2 - 81.6 ) 27.5 /
2008-11
All participants
17.5-25 kg/m2 119.7 ( 119.1 - 120.3 ) 70.8 ( 70.3 - 71.2 ) 8.0a 10.5a
≥25-30 kg/m2 126.2 ( 125.5 - 127.0 ) 74.7 ( 74.2 - 75.2 ) 17.9a 27.6a
≥30-40 kg/m2 128.5 ( 127.3 - 129.6 ) 75.4 ( 74.7 - 76.1 ) 24.4a 48.5a
Untreated participants
17.5-25 kg/m2 118.7 ( 118.0 - 119.4 ) 70.4 ( 69.9 - 70.8 ) 6.5a /
≥25-30 kg/m2 124.8 ( 124.0 - 125.7 ) 74.8 ( 74.2 - 75.4 ) 14.3a /
≥30-40 kg/m2 127.6 ( 126.3 - 129.0 ) 76.3 ( 75.4 - 77.3 ) 20.2a /
ap significant <0.05 for survey difference 1998 vs. 2008–11
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In this study, we found no association of BMI and SBP
within the group of untreated participants with hyper-
tension at both times. This finding is consistent with a
study which investigated the relationship of adiposity to
BP in African-American adults from Milwaukee as well
as non-Hispanic black and white adults from the 1999
to 2004 National Nutrition and Health Examination Sur-
vey (NHANES) waves. Here, BMI was significantly asso-
ciated with BP in normotensives but not in untreated
hypertensives among both Milwaukee and NHANES
participants. Even more, BMI was significantly associated
with SBP only in the lowest quartile of BP (SBP ≤ 115,
DBP ≤ 89) if normotensive and untreated hypertensive
persons were assessed together, which means, con-
versely, that already in the upper ranges of the normo-
tensive BP distribution, BMI was no longer associated
with SBP [26].
Since overweight and obese persons are more likely
treated with antihypertensives than normalweight per-
sons in our study, other influential factors (e.g. genetic
and environmental factors) than weight may have
contributed to BP elevation in this group of untreated
hypertensives.
In Germany, trends of SBP and BMI over time dif-
fered. While mean SBP and the prevalence of high
BP ≥140/90 mmHg decreased substantially in Germany
between 1998 and 2008–11 both in the overall sample and
in untreated persons, mean BMI remained constant on a
high level and the prevalence of obesity even slightly in-
creased in men. These developments were accompanied by
an improved management of hypertension and a consider-
able increase in antihypertensive medication use. World-
wide, the Global Burden of Metabolic Risk Factors of
Chronic Diseases project estimated a decrease in mean SBP
of −0.8 mmHg per decade in men and −1.0 mmHg in
women for the period from 1980 to 2008. In high-
income regions, like Western Europe and North America,
the estimated decrease was even higher and amounted
to −2.1 mmHg and −3.5 mmHg in Western European
men and women, respectively, and −2.8 mmHg in men
and −2.3 mmHg in women from North America [13].
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Fig. 1 Mean systolic blood pressure for participants within BMI ranges defined by BMI percentiles. BMI percentile ranges: P < 5, P5-P10, P10-P15
up to P95-P100. Curves represent predicted SBP values from univariable generalized linear regression models
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Table 3 Association between BMI and systolic blood pressure in 1998 and 2008-11
1998
Men Women
ß 95 %-CI combined p R2 ß 95 %-CI combined p R2
All participants
Unadjusted 0.066 0.112
BMI 2.939 ( 1.196 - 4.683 ) 0.000 3.700 ( 2.293 - 5.107 ) 0.000
BMI2 −0.034 ( −0.066 - −0.003 ) −0.045 ( −0.070 - −0.020 )
Adjusteda 0.216 0.374
BMI 1.013 ( −0.716 - 2.742 ) 0.000 0.351 ( −0.874 - 1.576 ) 0.000
BMI2 −0.007 ( −0.038 - 0.024 ) 0.002 ( −0.021 - 0.024 )
Untreated participants
Unadjusted 0.064 0.086
BMI 2.512 ( 0.789 - 4.235 ) 0.000 2.419 ( 0.960 3.878 ) 0.000
BMI2 −0.028 ( −0.060 - 0.003 ) −0.026 ( −0.053 0.001 )
Adjusted 0.195 0.299
BMI 0.571 ( −1.088 - 2.229 ) 0.000 −0.481 ( −1.935 0.972 ) 0.000




BMI 1.722 ( 0.443 - 3.000 ) 0.000 4.048 ( 2.613 - 5.483 ) 0.000
BMI2 −0.021 ( −0.044 - 0.001 ) −0.056 ( −0.083 - −0.030 )
Adjusted 0.056 0.221
BMI 0.728 ( −0.641 - 2.097 ) 0.000 1.943 ( 0.727 - 3.159 ) 0.000
BMI2 −0.006 ( −0.029 - 0.018 ) −0.026 ( −0.048 - −0.003 )
Untreated participants
Unadjusted 0.037 0.085
BMI 1.326 ( −0.175 - 2.827 ) 0.000 3.327 ( 1.719 - 4.936 ) 0.000
BMI2 −0.013 ( −0.040 - 0.014 ) −0.046 ( −0.077 - −0.015 )
Adjusted 0.088 0.203
BMI 0.699 ( −0.864 - 2.261 ) 0.000 1.433 ( 0.032 - 2.834 ) 0.000
BMI2 −0.003 ( −0.030 - 0.025 ) −0.014 ( −0.040 - 0.013 )
1998 and 2008–11 combined
All participants
Unadjusted 0.061 0.140
BMI 2.939 ( 1.196 - 4.683 ) 0.000 3.700 ( 2.293 - 5.107 ) 0.000
BMI2 −0.034 ( −0.066 - −0.003 ) −0.045 ( −0.070 - −0.020 )
BMI x surveyb −1.218 ( −3.251 - 0.815 ) 0.000 0.348 ( −1.589 - 2.284 ) 0.019
BMI2 x survey 0.013 ( −0.024 - 0.049 ) −0.011 ( −0.046 - 0.024 )
Adjusted 0.132 0.319
BMI 1.800 ( 0.121 - 3.479 ) 0.000 1.003 ( −0.220 - 2.226 ) 0.000
BMI2 −0.018 ( −0.048 - 0.012 ) −0.007 ( −0.029 - 0.016 )
BMI x survey −1.752 ( −3.637 - 0.132 ) 0.000 0.343 ( −1.252 - 1.938 ) 0.006
BMI2 x survey 0.022 ( −0.012 - 0.056 ) −0.011 ( −0.040 - 0.018 )
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globally by 0.4 kg/m2 per decade in men and 0.5 kg/m2
in women. In 2008, U.S. men and women thereby had
the highest mean BMI among high-income countries
and U.S. women also displayed the greatest BMI gain of
1.2 kg/m2 per decade. In contrast, Western Europe dis-
played a modest BMI increase of 0.6 kg/m2 per decade
in men and 0.4 kg/m2 in women.
Among children, a decrease in SBP but increase in BMI
and in the prevalence of overweight and obesity were ob-
served in some studies [25, 27, 28], whereas both SBP and
BMI increased in other paediatric populations [15, 29–31].
Diverging trends in the development of SBP and BMI were
observed in many populations [10, 14, 32, 33], although an
increase of both SBP and BMI was also observed, in par-
ticular for some developing countries [30, 31].
In summary, in congruence with other high-income
nations, mean SBP decreased in Germany during the last
decade, whereas mean BMI remained constant and obesity
prevalence in men increased. Concomitantly, the associ-
ation of BMI and SBP became weaker. In part, the weaken-
ing of the BMI-SBP-association may be attributable to
improvements in diagnosis and treatment of high BP.
Firstly, overweight and obese persons were more often
treated with antihypertensives in 2008–11 than in 1998.
More than one fourth of all overweight and half of all
obese were treated in 2008–11 and thus, the distribution
of SBP was truncated in a significant proportion of the
overweight population. In addition, since the treatment
prevalence was significantly higher in 2008–11 than in
1998, this could have contributed to a decreased associ-
ation. Secondly, the hypertension threshold had been
lowered to 140/90 mmHg only shortly before the 1998
survey [34]. It is likely that the new guidelines were bet-
ter implemented in 2008–11 than in 1998, i.e. more pa-
tients were treated at lower BP levels in 2008–11,
leaving a healthier group untreated in 2008–11 and thus
contributing to a decreased BMI-SBP-association also
among untreated persons.
It was argued by some authors that the correlation of
SBP and BMI observed in previous decades may have been
overestimated due to inappropriate BP cuffs in the obese
(undercuffing leading to overestimation of BP) [24, 35, 36].
The cuffs differed between GNHIES98 and DEGS1, al-
though both are in line with current BP measurement
guidelines [37]. As reported previously [21], this was inves-
tigated in a separate study with sequential measurements
with the GNHIES98 and DEGS1 devices and cuffs. A cali-
bration formula was derived which accounted not only for
Table 3 Association between BMI and systolic blood pressure in 1998 and 2008-11 (Continued)
Untreated participants
Unadjusted 0.058 0.116
BMI 2.512 ( 0.789 - 4.235 ) 0.000 2.419 ( 0.960 - 3.878 ) 0.000
BMI2 −0.028 ( −0.060 - 0.003 ) −0.026 ( −0.053 - 0.001 )
BMI x survey −1.186 ( −3.356 - 0.984 ) 0.005 0.908 ( −1.136 - 2.953 ) 0.330
BMI2 x survey 0.015 ( −0.024 - 0.055 ) −0.020 ( −0.058 - 0.019 )
Adjusted 0.141 0.274
BMI 1.260 ( −0.399 - 2.919 ) 0.000 0.007 ( −1.399 - 1.413 ) 0.000
BMI2 −0.008 ( −0.038 - 0.022 ) 0.011 ( −0.015 - 0.037 )
BMI x survey −1.089 ( −3.045 - 0.867 ) 0.011 0.921 ( −0.994 - 2.837 ) 0.560
BMI2 x survey 0.014 ( −0.021 - 0.050 ) −0.016 ( −0.052 - 0.020 )
a Adjusted for: age in 5 year intervals, antihypertensive medication, alcohol intake, sports activity, smoking status, socioeconomic status
b The combined models include survey year. Survey was coded as 0 = 1998, 1 = 2008–11
Table 4 Estimated increase in systolic blood pressure associated













20 to 25 kg/m2 7.0 6.2 3.8 3.7
25 to 30 kg/m2 5.3 4.8 2.7 3.0
30 to 35 kg/m2 3.6 3.4 1.7 2.4
Women
20 to 25 kg/m2 8.4 6.2 7.6 6.3
25 to 30 kg/m2 6.2 4.9 4.8 4.0
30 to 35 kg/m2 3.9 3.6 2.0 1.7
SBP increase was estimated based on unadjusted generalized linear
regression models
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device differences but also for the different ratios of cuff
width and arm circumference [21]. It is therefore not likely
that changes in the SBP-BMI- association between the two
surveys are due to cuff differences in the obese.
The strengths of this analysis include the nation-
wide population-based samples from two national
health surveys with largely identical sampling and
measurement methods, the standardisation of BP,
weight and height measurements and the availability
of high-quality medication data. It is a limitation of
our analysis that we could not adjust for the intake
of salt, fruit and vegetables which are related to both
BMI and BP. These parameters were either not mea-
sured or lacked comparability between the two sur-
veys. We included other possibly influential lifestyle
factors like sports activity, alcohol consumption and
smoking. However, their prevalence did not change
considerably between 1998 and 2008–11 and adjust-
ment for these factors did not change the BMI-SBP-
association very much compared to adjustment for
age only (data not shown).
Conclusions
For Germany, our analysis suggests a decrease in the
cross-sectional association of BMI and SBP particularly in
men which is in part explained by improvements in the
diagnosis and treatment of high BP. However, the associ-
ation has not disappeared as suggested by some analyses
from other countries. BMI remains significantly associated
with BP at the population level over a broad BMI range.
This suggests that a population-wide shift of the BMI dis-
tribution towards lower BMI values should remain a prior
public health issue.
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